The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Open accessAbstract
BACKGROUND: To determine whether a restrictive strategy of red-cell transfusion and a liberal strategy produced equivalent results in critically ill patients, we compared the rates of death from all causes at 30 days and the severity of organ dysfunction. METHODS: We enrolled 838 critically ill patients with euvolemia after initial treatment who had hemoglobin concentrations of less than 9.0 g per deciliter within 72 hours after admission to the intensive care unit and randomly assigned 418 patients to a restrictive strategy of transfusion, in which red cells were transfused if the hemoglobin concentration dropped below 7.0 g per deciliter and hemoglobin concentrations were maintained at 7.0 to 9.0 g per deciliter, and 420 patients to a liberal strategy, in which transfusions were given when the hemoglobin concentration fell below 10.0 g per deciliter and hemoglobin concentrations were maintained at 10.0 to 12.0 g per deciliter. RESULTS: Overall, 30-day mortality was similar in the two groups (18.7 percent vs. 23.3 percent, P= 0.11). However, the rates were significantly lower with the restrictive transfusion strategy among patients who were less acutely ill -- those with an Acute Physiology and Chronic Health Evaluation II score of < or =20 (8.7 percent in the restrictive-strategy group and 16.1 percent in the liberal-strategy group; P=0.03) -- and among patients who were less than 55 years of age (5.7 percent and 13.0 percent, respectively; P=0.02), but not among patients with clinically significant cardiac disease (20.5 percent and 22.9 percent, respectively; P=0.69). The mortality rate during hospitalization was significantly lower in the restrictive-strategy group (22.3 percent vs. 28.1 percent, P=0.05). CONCLUSIONS: A restrictive strategy of red-cell transfusion is at least as effective as and possibly superior to a liberal transfusion strategy in critically ill patients, with the possible exception of patients with acute myocardial infarction and unstable angina.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Transfusion requirements in in Critical Care trial (TRICC), which compared a restrictive transfusion threshold of 70 g/L versus 100 g/L in 838 euvolemic ICU patients, demonstrated no difference in the primary outcome (30-day mortality).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [484]
In the citing paper
“The results showed similar 90-day mortality, ischaemic events, and use of life support in the two treatment groups with fewer transfusions in the lower-threshold group.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [484]
In the citing paper
“In the subgroup of 218 patients with sepsis or septic shock 30-day mortality was similar in the two groups (22.8% in the restrictive group vs. 29.7% in the liberal group, p = 0.36).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [484]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients
Gattinoni, L., Brazzi, L., Pelosi, P. P., Latini, R., Tognoni, G., Pesenti, A. M., & Fumagalli, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331601 · Cited by 1,486
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
Carson, J. L., Duff, A., Poses, R. M., Berlin, J. A., Spence, R. K., Trout, R., Noveck, H., & Strom, B. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04330-9 · Cited by 994
Vichinsky, E. P., Haberkern, C. M., Neumayr, L., Earles, A. N., Black, D. M., Koshy, M., Pegelow, C. H., Abboud, M. R., Ohene‐Frempong, K., & Iyer, R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330402 · Cited by 644
van de Watering, L. M. G., Hermans, J., Houbiers, J. G. A., van den Broek, P. J., Bouter, H., Boer, F., Harvey, M. S., Huysmans, H. A., & Brand, A. (1998) · Circulation · doi:10.1161/01.cir.97.6.562 · Cited by 553
RBC transfusion in the ICU. Is there a reason?
Corwin, H., Parsonnet, K. C., & Gettinger, A. (1995) · Chest · doi:10.1378/chest.108.3.767 · Cited by 390
Biologic effects of leukocytes present in transfused cellular blood products
Bordin, J. O., Heddle, N., & Blajchman, M. A. (1994) · Blood · doi:10.1182/blood.v84.6.1703.bloodjournal8461703 · Cited by 357
Self-citationHébert, P. C., Wells, G. A., Tweeddale, M., Martin, C. M., Marshall, J., Pham, B., Blajchman, M. A., Schweitzer, I., & Pagliarello, G. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.5.9154866 · Cited by 348
Self-citation
Research works printed but not linked: 4
- Langenfeld JE, 1991, Surgery, 110, 398
- Baker CH, 1986, Circ Shock, 20, 127
- Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. St. Louis: Mosby-Year Book, 1996.
- Hebert PC, 1997, Can Med Assoc J, 156, S9
Cited by
Sorted by citations
Items 1,001–1,004 of 1,004
Wise, K. R., Akopov, V. A., Williams, B. R., Ido, M., Leeper, K. V., & Dressler, D. D. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.972 · Cited by 53
Clinical consequences of anemia and red cell transfusion in the critically ill
Hébert, P. C., McDonald, B. J., & Tinmouth, A. T. (2004) · Critical Care Clinics · doi:10.1016/j.ccc.2003.12.006 · Cited by 53
Self-citationDucrocq, G., Puymirat, E., Steg, P. G., Henry, P., Martelet, M., Karam, C., Schiele, F., Simon, T., & Danchin, N. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.004 · Cited by 32
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000298158.12101.41 · Cited by 9
Self-citation
Metadata
- Authors
- Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E.
- Affiliations
- University of Ottawa (CA)
- McMaster University (CA)
- University of Toronto (CA)
- Western University (CA)
- University of British Columbia (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-02-11
- Volume
- 340
- Issue
- 6
- Pages
- 409-417
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W127034668
- Cited by
- 5,187
- References
- 24
- Citations by year
- 2026: 88 · 2025: 121 · 2024: 123 · 2023: 116 · 2022: 124 · 2021: 137 · 2020: 188 · 2019: 173 · 2018: 168 · 2017: 231 · 2016: 256 · 2015: 246 · 2014: 287 · 2013: 269 · 2012: 254
- FWCI
- 79.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hamilton Health Sciences
- University of Waterloo
- Jewish General Hospital
- Topics
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- red blood cell transfusion, restrictive transfusion, liberal transfusion, critically ill patients, hemoglobin threshold, 30-day mortality, organ dysfunction, APACHE II score, age, heart disease, acute myocardial infarction, unstable angina
- MeSH terms
- Adult, Aged, Critical Care, Female, Hemoglobins, Humans, Intensive Care Units, Male, Middle Aged, Multiple Organ Failure, Logistic Models, Survival Analysis, Critical Illness, Hospital Mortality, Erythrocyte Transfusion, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
